Oppenheimer Asset Management Inc. Invests $3.17 Million in Plexus Corp. $PLXS

Oppenheimer Asset Management Inc. acquired a new stake in shares of Plexus Corp. (NASDAQ:PLXS) in the second quarter, Holdings Channel.com reports. The firm acquired 10,540 shares of the technology company’s stock, valued at approximately $3,169,000.

A number of other large investors have also made changes to their positions in the stock. Inspire Investing LLC grew its position in Plexus by 1.6% during the fourth quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock worth $467,000 after buying an additional 50 shares in the last quarter. Allworth Financial LP increased its stake in Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock valued at $44,000 after acquiring an additional 52 shares during the period. Maryland State Retirement & Pension System raised its holdings in Plexus by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock valued at $579,000 after acquiring an additional 60 shares in the last quarter. Trust Point Inc. raised its holdings in Plexus by 5.5% in the 2nd quarter. Trust Point Inc. now owns 1,308 shares of the technology company’s stock valued at $393,000 after acquiring an additional 68 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its position in shares of Plexus by 1.2% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock worth $908,000 after acquiring an additional 71 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on PLXS shares. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price for the company in a research note on Friday, July 31st. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Raymond James Financial reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Plexus in a research report on Thursday, April 30th. Finally, Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $273.00.

Plexus Stock Up 1.3%

Shares of PLXS opened at $267.41 on Friday. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average price of $272.41 and a two-hundred day moving average price of $240.31. The stock has a market cap of $7.16 billion, a price-to-earnings ratio of 39.44 and a beta of 0.90. Plexus Corp. has a 12 month low of $126.86 and a 12 month high of $307.06.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The company had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the prior year, the company posted $1.64 EPS. The company’s revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities analysts predict that Plexus Corp. will post 7.11 EPS for the current fiscal year.

Key Headlines Impacting Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Needham analyst David Williams reiterated a Buy rating and maintained a $310 price target, implying roughly 16% upside from the recently referenced share price. The analyst cited a stronger revenue outlook. Analyst reiterates Buy on Plexus as revenue outlook surges
• Positive Sentiment: Zacks Research upgraded Plexus from Hold to Strong Buy and sharply increased its EPS forecasts across fiscal 2026-2028. Estimates rose to $7.02 for fiscal 2026, $8.50 for fiscal 2027 and $9.42 for fiscal 2028, indicating expectations for accelerating profitability. Earnings estimates rising for Plexus
• Positive Sentiment: The company’s latest quarterly report showed EPS of $2.32 versus the $2.13 consensus estimate and revenue of $1.30 billion versus expectations of $1.23 billion. Revenue increased 28.2% year over year, while fourth-quarter guidance calls for EPS of $2.47 to $2.63.
• Positive Sentiment: Recent institutional activity was supportive, including new or expanded positions by BlackRock, Bank of New York Mellon and Victory Capital. Institutions and hedge funds collectively own approximately 94.45% of PLXS shares.
• Neutral Sentiment: Despite the bullish revisions, Plexus trades at a relatively elevated valuation, with a price-to-earnings ratio near 39. Consensus analyst coverage remains favorable overall, with an average rating of Buy and a consensus price target near $273.
• Negative Sentiment: Director Michael Schrock sold 4,000 shares for approximately $1.1 million, reducing his position by 9.02%. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, which reduces its significance as a discretionary bearish signal. Plexus director sells stock

Insider Activity at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $294.98, for a total transaction of $442,470.00. Following the completion of the transaction, the chief executive officer directly owned 68,888 shares in the company, valued at $20,320,582.24. This represents a 2.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of Plexus stock in a transaction on Friday, June 5th. The shares were sold at an average price of $272.17, for a total value of $138,806.70. Following the transaction, the insider directly owned 665 shares of the company’s stock, valued at approximately $180,993.05. The trade was a 43.40% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 9,510 shares of company stock valued at $2,625,182 in the last 90 days. 1.78% of the stock is owned by corporate insiders.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.